Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Russano

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|May 29, 2020
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samplesMarco Russano, Andrea Napolitano, Giulia Ribelli, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 26, 2020
Correction to: Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samplesMarco Russano, Andrea Napolitano, Giulia Ribelli, et al.
Cancers|February 10, 2021
Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related PneumonitisCarlo Augusto Mallio, Andrea Napolitano, Gennaro Castiello, et al.
Pathologica|October 8, 2024
A preliminary study on the diagnostic performance of the uPath PD-L1 (SP263) artificial intelligence (AI) algorithm in patients with NSCLC treated with PD-1/PD-L1 checkpoint blockadeAlessio Cortellini, Claudia Zampacorta, Michele De Tursi, et al.
Recenti Progressi in Medicina|July 1, 2023
[Management of the patient with extensive stage microcytoma. The importance of collaboration between oncology and radiotherapy.]Gabriele Minuti, Alessio Stefani, Luca Trodella, et al.
Clinical Lung Cancer|January 18, 2026
Osimertinib-Induced Lung Injury and Treatment Rechallenge: Clinical Insights From a Case Report With a Comprehensive Literature ReviewFabrizio Citarella, Emanuele C Mingo, Matteo Fiorenti, et al.
Critical Reviews in Oncology/Hematology|August 26, 2023
New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists - INTERACTION groupChiara Catania, Andrea Riccardo Filippi, Claudia Sangalli, et al.
Recenti Progressi in Medicina|October 14, 2021
[Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.]Gabriele Minuti, Alessio Stefani, Silvia Carpano, et al.
Journal of Chemotherapy (Florence, Italy)|August 6, 2024
Induction chemotherapy backbone in frail patients with advanced NSCLC treated with chemotherapy plus pembrolizumab: a single institution retrospective audit of dose intensities from modified regimensAlessio Cortellini, Fabrizio Citarella, Alessia Vendittelli, et al.
Critical Reviews in Oncology/Hematology|July 2, 2021
Exploring the role of respiratory microbiome in lung cancer: A systematic reviewFabiana Perrone, Lorenzo Belluomini, Marco Mazzotta, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Journal of Experimental & Clinical Cancer Research : CR|May 29, 2020
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samplesMarco Russano, Andrea Napolitano, Giulia Ribelli, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 26, 2020
Correction to: Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samplesMarco Russano, Andrea Napolitano, Giulia Ribelli, et al.
Cancers|February 10, 2021
Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related PneumonitisCarlo Augusto Mallio, Andrea Napolitano, Gennaro Castiello, et al.
Pathologica|October 8, 2024
A preliminary study on the diagnostic performance of the uPath PD-L1 (SP263) artificial intelligence (AI) algorithm in patients with NSCLC treated with PD-1/PD-L1 checkpoint blockadeAlessio Cortellini, Claudia Zampacorta, Michele De Tursi, et al.
Recenti Progressi in Medicina|July 1, 2023
[Management of the patient with extensive stage microcytoma. The importance of collaboration between oncology and radiotherapy.]Gabriele Minuti, Alessio Stefani, Luca Trodella, et al.
Clinical Lung Cancer|January 18, 2026
Osimertinib-Induced Lung Injury and Treatment Rechallenge: Clinical Insights From a Case Report With a Comprehensive Literature ReviewFabrizio Citarella, Emanuele C Mingo, Matteo Fiorenti, et al.
Critical Reviews in Oncology/Hematology|August 26, 2023
New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists - INTERACTION groupChiara Catania, Andrea Riccardo Filippi, Claudia Sangalli, et al.
Recenti Progressi in Medicina|October 14, 2021
[Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.]Gabriele Minuti, Alessio Stefani, Silvia Carpano, et al.
Journal of Chemotherapy (Florence, Italy)|August 6, 2024
Induction chemotherapy backbone in frail patients with advanced NSCLC treated with chemotherapy plus pembrolizumab: a single institution retrospective audit of dose intensities from modified regimensAlessio Cortellini, Fabrizio Citarella, Alessia Vendittelli, et al.
Critical Reviews in Oncology/Hematology|July 2, 2021
Exploring the role of respiratory microbiome in lung cancer: A systematic reviewFabiana Perrone, Lorenzo Belluomini, Marco Mazzotta, et al.
Pageof 8